Skip to content

Impinj, Inc. PI Non-cash interest expense

Non-cash interest expense at other companies

Ligand Pharmaceuticals logo
Ligand PharmaceuticalsLGND
Intuitive Machines, Inc. logo
Intuitive Machines, Inc.LUNR

Other financials

Income statement

See full
Revenue$74.3M0.0%
Gross profit$36.5M-0.6%
Operating income-$15.2M-58.5%
Net income-$25.3M-199%
EPS (diluted)-$0.83-177%

Balance sheet

See full
Cash & equivalents$32.3M-47.3%
Total debt$265.1M-9.3%
Total equity$203.9M+27.0%
Total assets$502.5M+4.7%

Cash flow

See full
Operating cash flow$4.0M+136%
CapEx$1.7M-6.2%
Free cash flow$2.2M+117%

Valuation

See full
Market cap$3.81B+19.9%

Profitability

See full
Gross margin52.5%+0.8pp
Operating margin-1.8%+0.8pp
Net margin-7.7%-8.1pp
FCF margin16.9%+4.8pp

Returns & leverage

See full
Return on equity-15.2%-16.6pp
Debt / equity1.3×-0.5×
Current ratio9.2×-1.8×

Where this comes from

Reported directly by Impinj, Inc. in its filing.

Tagged under the XBRL concept us-gaap:AmortizationOfFinancingCostsAndDiscounts.

The official record: Impinj, Inc.’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Impinj, Inc.'s non-cash interest expense.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Impinj, Inc.'s non-cash interest expense?
Impinj, Inc. (PI) reported non-cash interest expense of $517K in Q1 2026.
How has Impinj, Inc.'s non-cash interest expense changed year-over-year?
Impinj, Inc.'s non-cash interest expense increased by 24.9% year-over-year, from $414K to $517K.
What is the long-term trend for Impinj, Inc.'s non-cash interest expense?
Over 4 years (2021 to 2025), Impinj, Inc.'s non-cash interest expense has grown at a 33.4% compound annual growth rate (CAGR), from $568K to $1.8M.